[1] |
Sung H,Ferlay J,Siegel RL,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209–249.
|
[2] |
Cao W,Chen HD,Yu YW,et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J(Engl), 2021, 134(7): 783–791.
|
[3] |
Creasy JM,Sadot E,Koerkamp BG,et al. Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?[J]. Surgery, 2018, 163(6): 1238–1244.
|
[4] |
郭飞,薛军,韩磊,等. Galon免疫评分联合围手术期NRS对结直肠癌患者术后预后的预测价值研究[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(04): 361–365.
|
[5] |
Meyer Y,Olthof PB,Grünhagen DJ,et al. Treatment of metachronous colorectal cancer metastases in the Netherlands: A population-based study[J]. Eur J Surg Oncol, 2022, 48(5): 1104–1109.
|
[6] |
周津卉,谢锋,阮骊韬,等. 改良格拉斯哥评分和血清癌胚抗原水平对结直肠癌肝转移的预测价值[J]. 实用肿瘤杂志, 2022, 37(05): 424–432.
|
[7] |
程煌荣,郑勇斌. 结直肠癌患者肿瘤静脉血CTCs和CEA mRNA水平对异时性肝转移的预测价值[J]. 现代肿瘤医学, 2021, 29(02): 263–266.
|
[8] |
白雪杉,林国乐. 2019.V1版《NCCN结直肠癌诊治指南》更新要点解析[J]. 中国全科医学, 2019, 22(33): 4031–4034.
|
[9] |
姚智航,张凯,骆银根,等. 热消融与手术切除治疗异时性结直肠癌肝转移的临床疗效比较[J]. 四川大学学报(医学版), 2022, 53(03): 481–487.
|
[10] |
Sendi H,Yazdimamaghani M,Hu M,et al. Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis[J]. Cancer Res, 2022, 82(1): 105–113.
|
[11] |
姜福全,孙培鸣,闫洪峰,等. 结直肠癌根治术患者不同体重与手术结局关系的回顾性研究[J/CD]. 中华普外科手术学杂志(电子版), 2021, 15(03): 290–293.
|
[12] |
Meyer Y,Olthof PB,Grünhagen DJ,et al. Treatment of metachronous colorectal cancer metastases in the Netherlands: A population-based study[J]. Eur J Surg Oncol, 2022, 48(5): 1104–1109.
|
[13] |
Molla M,Fernandez-Plana J,Albiol S,et al. Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment,Surgery,Ablation or SBRT[J]. J Clin Med, 2021, 10(10): 2131.
|
[14] |
李洪波,袁静静,张佃良,等. 周围神经侵犯与结直肠癌患者预后的相关性分析[J]. 中国现代普通外科进展, 2022, 25(06): 432–435.
|
[15] |
井海燕,田春方,裴庆山,等. T1期结直肠癌64例淋巴结转移危险因素和黏膜下深浸润临床意义的分析[J]. 中华消化杂志, 2021, 41(11): 770–774.
|
[16] |
姚晓萌,郑琳琳,孙茹梦,等. 胃肠胰神经内分泌肿瘤同步肝转移的相关因素分析以及预测模型建立[J]. 胃肠病学, 2021, 26(07): 424–428.
|
[17] |
Baird DLH,Kontovounisios C,Simillis C,et al. Factors associated with metachronous metastases and survival in locally advanced and recurrent rectal cancer[J]. BJS Open, 2020, 4(6): 1172–1179.
|
[18] |
程晨,吴云桦,徐正水,等. Ⅱ~Ⅲ期结肠癌根治术后复发危险因素分析及其列线图预测模型的应用价值[J]. 中华消化外科杂志, 2021, 20(03): 331–338.
|
[19] |
冯婷婷,陈众众,闫文锦,等. 基于SEER数据库的肿瘤直径大于7.0厘米的非小细胞肺癌患者预后分析[J]. 肿瘤防治研究, 2021, 48(01): 49–54.
|
[20] |
Hu S,Li S,Teng D,et al. Analysis of risk factors and prognosis of 253 lymph node metastasis in colorectal cancer patients[J]. BMC Surg, 2021, 21(1): 280.
|
[21] |
张振毫. 循环肿瘤细胞检测对结直肠癌患者根治术后异时性肝转移的预测价值分析[J]. 解放军医药杂志, 2018, 30(06): 18–21.
|
[22] |
程煌荣,郑勇斌. 结直肠癌患者肿瘤静脉血CTCs和CEA mRNA水平对异时性肝转移的预测价值[J]. 现代肿瘤医学, 2021, 29(02): 263–266.
|